DaanishHodaMD

Oncology • Salt Lake City, UT

Hematologic Oncology

Oncology Program Associate Medical Director of Hematology Intermountain Health

Join to view full profile

Dr. Hoda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hoda's full profile

Already have an account?

Office
8 8th Ave
# Lds
Salt Lake City, UT 84143
Phone+1 801-408-1819

Summary

Dr. Hoda is an Oncology Program Associate Medical Director of Hematology and works at the Intermountain Health's Hematologic Malignancy Program performing high risk leukemia treatments and stem cell transplants, and oversees the Classical Hematology Virtual Clinic.

Education & Training

University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2006 - 2009
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2002 - 2005
University of Miami Leonard M. Miller School of MedicineClass of 2002

Certifications & Licensure

UT State Medical License 2009 - 2026
CO State Medical License 2020 - 2025
ID State Medical License 2020 - 2025
MT State Medical License 2019 - 2025
NV State Medical License 2020 - 2025
FL State Medical License 2006 - 2011
MN State Medical License 2003 - 2005
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients Start of enrollment: 2013 Aug 01
Completed
Phase 3

Publications & Presentations

PubMed

1 citations
OUTREACH: phase 2 study of lisocabtagene maraleucel as outpatient or inpatient treatment at community sites for R/R LBCL.
Yuliya Linhares, Cesar O Freytes, Mohamad Cherry, Carlos Bachier, Michael Maris
Blood Advances. 2024-12-10
Multiplexed gastrointestinal PCR panels for the evaluation of diarrhea in patients with acute leukemia.
Clyde D Ford, Bert K Lopansri, Bradley D Hunter, Jacob Wilkes, Julie Asch
Infection Control and Hospital Epidemiology. 2024-11-08
1 citations
Multiplexed Gastrointestinal PCR Panels for the Evaluation of Diarrhea in Hematopoietic Stem Cell Transplantation Recipients.
Clyde D Ford, Bert K Lopansri, Bradley D Hunter, Julie Asch, Daanish Hoda
Transplantation and Cellular Therapy. 2024-08-01

Abstracts/Posters

Equate, a Phase 1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of a Novel Targeted Anti-CD6 Therapy, Itolizu...
Daanish Hoda, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

ASH Recognizes Choosing Wisely, Guideline Implementation ChampionsDecember 29th, 2022
14 More Utahns Die of COVID-19. And, Yes, We’re Still in a SurgeJuly 7th, 2022
Approval of Blood Plasma Treatment Has Implications for Utah’s COVID-19 Patients and ResearchersAugust 24th, 2020
Join now to see all